Literature DB >> 28781063

SGLT2 inhibitors in the real world: too good to be true?

David Fitchett1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28781063     DOI： 10.1016/S2213-8587(17)30259-0

Source DB:  PubMed          Journal:  Lancet Diabetes Endocrinol        ISSN： 2213-8587            Impact factor:   32.069


× No keyword cloud information.
  5 in total

1.  Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis.

Authors:  E G Dorsey-Treviño; J G González-González; N Alvarez-Villalobos; V González-Nava; B M Contreras-Garza; A Díaz González-Colmenero; G Rodríguez-Tamez; F J Barrera-Flores; A M Farrell; V M Montori; R Rodriguez-Gutierrez
Journal:  J Endocrinol Invest       Date:  2019-09-05       Impact factor: 4.256

Review 2.  Translating recent results from the Cardiovascular Outcomes Trials into clinical practice: recommendations from the Central and Eastern European Diabetes Expert Group (CEEDEG).

Authors:  Guntram Schernthaner; Roger Lehmann; Martin Prázný; Leszek Czupryniak; Kristine Ducena; Peter Fasching; Andrej Janež; Avraham Karasik; Peter Kempler; Emil Martinka; Marina V Shestakova; Lea Smirčić Duvnjak; Tsvetalina Tankova
Journal:  Cardiovasc Diabetol       Date:  2017-10-23       Impact factor: 9.951

3.  Effectiveness of long-term treatment with SGLT2 inhibitors: real-world evidence from a specialized diabetes center.

Authors:  Yotsapon Thewjitcharoen; Nalin Yenseung; Areeya Malidaeng; Soontaree Nakasatien; Phawinpon Chotwanvirat; Sirinate Krittiyawong; Ekgaluck Wanothayaroj; Thep Himathongkam
Journal:  Diabetol Metab Syndr       Date:  2017-12-01       Impact factor: 3.320

Review 4.  Cardiovascular effects of sodium glucose cotransporter 2 inhibitors.

Authors:  Tricia Santos Cavaiola; Jeremy Pettus
Journal:  Diabetes Metab Syndr Obes       Date:  2018-04-12       Impact factor: 3.168

5.  Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?

Authors:  Shih-Chieh Shao; Yi-Han Lin; Kai-Cheng Chang; Yuk-Ying Chan; Ming-Jui Hung; Yea-Huei Kao Yang; Edward Chia-Cheng Lai
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.